Companies: 10,795·Total market cap: $144.5T
CanSino Biologics Inc.

CanSino Biologics Inc.

CASBFOTCHealthcare● Active
$3.97
+$0.97(+32.33%)
Market Cap$1.4B
P/E Ratio
52W High$6.99
52W Low$3
Overview

CanSino Biologics Inc.(CASBF)· 现金流量表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · CASBF · 截至 2026-06-10

财务报表

Operating CF · CapEx · Free Cash Flow
Breakdown2025-122024-122023-122022-122021-12
Operating Activities
Net Income$0.03B($0.38B)($1.98B)($1.18B)$1.91B
Depreciation & Amort.$0.17B$0.21B$0.27B$0.20B$0.09B
Stock-Based Comp.$0.00B$0.00B$0.01B$0.01B$0.01B
Change in Working Capital($0.16B)($0.12B)($0.16B)($1.48B)$0.08B
Net Cash from Operations$0.03B($0.17B)($0.91B)($1.89B)$2.01B
Investing Activities
Capital Expenditure($0.19B)($0.46B)($0.61B)($1.08B)($1.20B)
Purchases of Investments($7.43B)($12.93B)($8.09B)($12.36B)($8.48B)
Sales of Investments$8.01B$13.42B$8.30B$12.21B$7.12B
Net Cash from Investing$0.36B$0.00B($0.45B)($1.19B)($2.53B)
Financing Activities
Common Stock Repurchased$0.00B($0.01B)$0.00B($0.15B)$0.00B
Dividends Paid$0.00B($0.06B)($0.00B)($0.19B)($0.01B)
Debt Issued / Repaid($0.70B)($0.26B)$0.07B$1.27B$0.99B
Net Cash from Financing($0.70B)($0.33B)($0.01B)$0.85B$1.56B
Free Cash Flow
Free Cash Flow($0.15B)($0.63B)($1.53B)($2.96B)$0.81B
FCF Margin %(computed)-14.81%-75.94%-442.29%-287.34%18.87%

数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · CNY · B

深入了解CanSino Biologics Inc.

关于CanSino Biologics Inc.(CASBF)现金流量表

CanSino Biologics Inc. 2025财年经营活动现金流$0.03B,自由现金流($0.15B)(FCF利润率-14.81%),资本支出($0.19B)。

常见问题

CASBF · 4 问

CanSino Biologics Inc. 2025财年自由现金流($0.15B),同比up75.6%。

CASBF free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10